DexCom (DXCM) PT Raised to $450 at Oppenheimer
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.56 -0.21%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Oppenheimer analyst Steven Lichtman raised the price target on DexCom (NASDAQ: DXCM) to $450.00 (from $445.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Johnson Rice Downgrades Expand Energy (EXE) to Accumulate
- Solana Co. (HSDT) PT Lowered to $2.50 at B.Riley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
